These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35935797)

  • 1. Factors associated with mood disorders and the efficacy of the targeted treatment of functional dyspepsia: A randomized clinical trial.
    Huang Q; Zheng S; Cai T; Zhang S; Su Q; Wang F
    Front Med (Lausanne); 2022; 9():859661. PubMed ID: 35935797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitors for functional dyspepsia.
    Pinto-Sanchez MI; Yuan Y; Bercik P; Moayyedi P
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011194. PubMed ID: 28271513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of clinician-patient communication on compliance with flupentixol-melitracen in functional dyspepsia patients.
    Yan XJ; Li WT; Chen X; Wang EM; Liu Q; Qiu HY; Cao ZJ; Chen SL
    World J Gastroenterol; 2015 Apr; 21(15):4652-9. PubMed ID: 25914475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chinese Herbal Medicine for Functional Dyspepsia With Psychological Disorders: A Systematic Review and Meta-Analysis.
    Luo X; Wang L; Fang S; Qing X; Jiang T; Yang Y; Su X; Wei W
    Front Neurosci; 2022; 16():933290. PubMed ID: 35911981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton Pump Inhibitors Reduce Duodenal Eosinophilia, Mast Cells, and Permeability in Patients With Functional Dyspepsia.
    Wauters L; Ceulemans M; Frings D; Lambaerts M; Accarie A; Toth J; Mols R; Augustijns P; De Hertogh G; Van Oudenhove L; Tack J; Vanuytsel T
    Gastroenterology; 2021 Apr; 160(5):1521-1531.e9. PubMed ID: 33346007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of sleep disorders in Japanese patients with functional dyspepsia (FD): nizatidine improves clinical symptoms, gastric emptying and sleep disorders in FD patients.
    Futagami S; Yamawaki H; Izumi N; Shimpuku M; Kodaka Y; Wakabayashi T; Nagoya H; Shindo T; Kawagoe T; Gudis K; Itoh T; Sakamoto C
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1314-20. PubMed ID: 23611167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of acid in functional dyspepsia].
    Tomita T; Oshima T; Fukui H; Watari J; Miwa H
    Nihon Rinsho; 2015 Jul; 73(7):1202-8. PubMed ID: 26165081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatments for functional nausea and functional dyspepsia in children: a systematic review.
    Browne PD; Nagelkerke SCJ; van Etten-Jamaludin FS; Benninga MA; Tabbers MM
    Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1195-1208. PubMed ID: 30360666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender difference in the overlap of irritable bowel syndrome and functional dyspepsia: a prospective nationwide multicenter study in Korea.
    Nam K; Kim N; Song HJ; Baik GH; Choi SC; Kim HJ; Lee JY; Park KS; Park SY; Park SJ
    J Gastroenterol; 2021 Jun; 56(6):537-546. PubMed ID: 33687537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Shenqu Xiaoshi Oral Liquid Compared With Domperidone Syrup in Children With Functional Dyspepsia.
    Yu Y; Xie XL; Wu J; Li ZY; He ZG; Liang CJ; Jin ZQ; Wang AZ; Gu J; Huang Y; Mei H; Shi W; Hu SY; Jiang X; Du J; Hu CJ; Gu L; Jiang ML; Mao ZQ; Xu CD
    Front Pharmacol; 2022; 13():831912. PubMed ID: 35185585
    [No Abstract]   [Full Text] [Related]  

  • 11. Insights into the evaluation and management of dyspepsia: recent developments and new guidelines.
    Black CJ; Houghton LA; Ford AC
    Therap Adv Gastroenterol; 2018; 11():1756284818805597. PubMed ID: 30397412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors versus histamine-2 receptor antagonists for stress ulcer prophylaxis during extracorporeal membrane oxygenation: a propensity score-matched analysis.
    Kondo Y; Ohbe H; Matsui H; Fushimi K; Tanaka H; Yasunaga H
    BMJ Open; 2020 Sep; 10(9):e037534. PubMed ID: 32994240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: an updated systematic review and network meta-analysis of randomized trials.
    Wang Y; Ge L; Ye Z; Siemieniuk RA; Reintam Blaser A; Wang X; Perner A; Møller MH; Alhazzani W; Cook D; Guyatt GH
    Intensive Care Med; 2020 Nov; 46(11):1987-2000. PubMed ID: 32833040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zhizhu Kuanzhong Capsule in treating patients with functional dyspepsia postprandial distress syndrome: study protocol for a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial.
    Xiao M; Zhong LLD; Lam WC; Zhao Y; Gwee KA; Holtmann G; Tack J; Suzuki H; Chen MH; Xiao Y; Hou X; Liu J; Li Y; Tang XD; Lu F
    Trials; 2022 Jun; 23(1):454. PubMed ID: 35655286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Clidinium/Chlordiazepoxide as an Add-on Therapy in Functional Dyspepsia: A Randomized, Controlled, Trial.
    Puasripun S; Thinrungroj N; Pinyopornpanish K; Kijdamrongthum P; Leerapun A; Chitapanarux T; Thongsawat S; Praisontarangkul OA
    J Neurogastroenterol Motil; 2020 Apr; 26(2):259-266. PubMed ID: 32235033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who is using chronic acid suppression therapy and why?
    Jacobson BC; Ferris TG; Shea TL; Mahlis EM; Lee TH; Wang TC
    Am J Gastroenterol; 2003 Jan; 98(1):51-8. PubMed ID: 12526936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.
    Sakaguchi M; Takao M; Ohyama Y; Oka H; Yamashita H; Fukuchi T; Ashida K; Murotani M; Murotani M; Majima K; Morikawa H; Hashimoto T; Kiyota K; Esaki H; Amemoto K; Isowa G; Takao F
    World J Gastroenterol; 2012 Apr; 18(13):1517-24. PubMed ID: 22509084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acupuncture for functional dyspepsia.
    Lan L; Zeng F; Liu GJ; Ying L; Wu X; Liu M; Liang FR
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008487. PubMed ID: 25306866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
    Landi SN; Sandler RS; Pate V; Lund JL
    Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.